AMENDED AND RESTATED SUPPLY AGREEMENT between LAWRENCE LABORATORIES, an operating division of Swords Laboratories and CADENCE PHARMACEUTICALS, INC. effective as of February 22, 2013Supply Agreement • February 28th, 2013 • Cadence Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amended and Restated Supply Agreement (the “Agreement”) is entered into and is effective as of February 22, 2013 (the “Effective Date”) by and among Lawrence Laboratories, an operating division of Swords Laboratories, which is organized under the laws of Ireland with its registered office at Unit 12, Distribution Centre, Shannon Industrial Estate, Shannon, County Clare, Ireland (“LL”), and Cadence Pharmaceuticals, Inc., a Delaware corporation having an address at 12481 High Bluff Drive, Suite 200, San Diego, California 92130 (“Cadence”). LL is also a member of the Bristol Myers Squibb Company (“BMS”) group of companies. LL and Cadence are sometimes collectively referred to herein collectively as the “Parties” and each individually as a “Party.”
